Gene · 427
Papers1,873
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,873
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Obesity and myeloma: Clinical and mechanistic contributions to disease progression. | Front Endocrinol (Lausanne) | 2023 | 36909335 | PubTator, text mining | PubMed |
| Fatty Acid 2-Hydroxylase and 2-Hydroxylated Sphingolipids: Metabolism and Function in Health and Diseases. | Int J Mol Sci | 2023 | 36902339 | PubTator, text mining | PubMed |
| Zebra-Sphinx: Modeling Sphingolipidoses in Zebrafish. | Int J Mol Sci | 2023 | 36902174 | PubTator, text mining | PubMed |
| Sphingolipids in neurodegenerative diseases. | Front Neurosci | 2023 | 36875645 | PubTator, text mining | PubMed |
| The progress in our understanding of CIN in breast cancer research. | Front Oncol | 2023 | 36874134 | PubTator, text mining | PubMed |
| A novel SEMA6B variant causes adult-onset progressive myoclonic epilepsy-11 in a Chinese family: A case report and literature review. | Front Genet | 2023 | 36873942 | PubTator, text mining | PubMed |
| Determination of factors affecting customer satisfaction towards "maynilad" water utility company: A structural equation modeling-deep learning neural network hybrid approach. | Heliyon | 2023 | 36873542 | PubTator, text mining | PubMed |
| Differentially Expressed Heterogeneous Overdispersion Genes Testing for Count Data. | bioRxiv | 2023 | 36865247 | PubTator, text mining | PubMed |
| Exploring the role of sphingolipid-related genes in clinical outcomes of breast cancer. | Front Immunol | 2023 | 36860848 | PubTator, text mining | PubMed |
| Mitochondrial cholesterol: Metabolism and impact on redox biology and disease. | Redox Biol | 2023 | 36857930 | PubTator, text mining | PubMed |
| Involvement of Lipids in the Pathogenesis of Amyotrophic Lateral Sclerosis. | Life (Basel) | 2023 | 36836867 | PubTator, text mining | PubMed |
| Gene Therapy of Sphingolipid Metabolic Disorders. | Int J Mol Sci | 2023 | 36835039 | PubTator, text mining | PubMed |
| Horse-Derived Ceramide Accentuates Glucosylceramide Synthase and Ceramide Synthase 3 by Activating PPARβ/δ and/or PPARγ to Stimulate Ceramide Synthesis. | Biomedicines | 2023 | 36831084 | PubTator, text mining | PubMed |
| Acid Ceramidase Deficiency: Bridging Gaps between Clinical Presentation, Mouse Models, and Future Therapeutic Interventions. | Biomolecules | 2023 | 36830643 | PubTator, text mining | PubMed |
| Transcriptomic Profiling and Pathway Analysis of Mesenchymal Stem Cells Following Low Dose-Rate Radiation Exposure. | Antioxidants (Basel) | 2023 | 36829800 | PubTator, text mining | PubMed |
| Mechanisms of Glucocerebrosidase Dysfunction in Parkinson's Disease. | J Mol Biol | 2023 | 36828270 | PubTator, text mining | PubMed |
| Ubiquitin specific peptidases and prostate cancer. | PeerJ | 2023 | 36811009 | PubTator, text mining | PubMed |
| Role of ceramides in diabetic foot ulcers (Review). | Int J Mol Med | 2023 | 36799149 | PubTator, text mining | PubMed |
| The Critical Impact of Sphingolipid Metabolism in Breast Cancer Progression and Drug Response. | Int J Mol Sci | 2023 | 36768427 | PubTator, text mining | PubMed |
| Acid ceramidase involved in pathogenic cascade leading to accumulation of α-synuclein in iPSC model of GBA1-associated Parkinson's disease. | Hum Mol Genet | 2023 | 36752535 | Swiss-Prot, curated | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/427/papers?page=14